0000950103-12-001924.txt : 20120413 0000950103-12-001924.hdr.sgml : 20120413 20120413071456 ACCESSION NUMBER: 0000950103-12-001924 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20120412 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120413 DATE AS OF CHANGE: 20120413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shire plc CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 12757458 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: R924 8EP BUSINESS PHONE: 441256894000 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: R924 8EP FORMER COMPANY: FORMER CONFORMED NAME: Shire Ltd. DATE OF NAME CHANGE: 20080523 FORMER COMPANY: FORMER CONFORMED NAME: Shire plc DATE OF NAME CHANGE: 20051125 FORMER COMPANY: FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC DATE OF NAME CHANGE: 19980302 8-K 1 dp29948_8k.htm FORM 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): April 12, 2012

Shire plc
_________________________________________________________________________

(Exact name of registrant as specified in its charter)

Jersey, Channel Islands
_________________________________________________________________________

(State or other jurisdiction of incorporation)

0-29630                                                  98-0601486
(Commission File Number)                (IRS Employer Identification No.)

5 Riverwalk, Citywest Business Campus, Dublin
24, Republic of Ireland
_________________________________________________________________________

(Address of principal executive offices)                              (Zip code)

Registrant's telephone number, including area code               +353 1 429 7700
_________________________________________________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 8.01.      Other Events

Shire plc has issued the press release attached hereto as Exhibit 99.01 which is incorporated by reference herein.


Item 9.01.      Financial Statements and Exhibits

(d)  Exhibits.  The following exhibit is filed herewith:

99.01           Press Release dated April 12, 2012
 
 
 
 
 

SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
SHIRE PLC
  
     
         
         
  By:   
/s/ A C Russell
  
    Name:    Angus Russell  
    Title:  Chief Executive Officer  
 
Dated: April 12, 2012
 
 
 
 

 
EXHIBIT INDEX
 
Number
 
Description
99.01
Press release dated April 12, 2012
 
 
 
 EX-99.1 2 dp29948_9901.htm EXHIBIT 99.1
 
Exhibit 99.01
 
Press Release
www.shire.com
  
 
 
First quarter 2012 results date notification – April 26, 2012

Dublin, Ireland – April 12, 2012 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce first quarter 2012 earnings on Thursday April 26, 2012.

Results press release will be issued at:
12:00 BST / 07:00 EDT
Investor conference call time:
14:00 BST / 09:00 EDT

Live conference call for investors:
Angus Russell, Chief Executive Officer and Graham Hetherington, Chief Financial Officer will host the investor and analyst conference call at 14:00 BST/9:00 EDT.

The details of the conference call are as follows:

UK dial in:
0800 077 8492 or 0844 335 0351
US dial in:
1 866 8048688 or 1 718 3541175
International dial in:
+44 844 335 0351
Global Access Numbers:
http://www.btconferencing.com/globalaccess/?bid=54_attended
Password/Conf ID:
338 270
Live Webcast:
http://www.shire.com/shireplc/en/investors

Replay:
A replay of the presentation will be available for two weeks by phone and by webcast for one year.  Details can be found on our Investor Relations website http://www.shire.com/shireplc/en/investors.

For further information please contact:

Investor Relations
Souheil Salah (ssalah@shire.com)
+44 1256 894 160
 
Erin K. Kelly (erikelly@shire.com)
+1 781 482 9541

Notes to editors

SHIRE PLC
Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.  Shire’s in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.  Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company’s website: www.shire.com.
 
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
 
 GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(" M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@," M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$! M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,` M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I M*C0U-CH.$A8:' MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7 MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1 M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`#8`Q`,!$0`"$0$#$0'_V@`, M`P$``A$#$0`_`/W\H`*`"@`H`^=/VB?VF?A_^S?X=M]3\4-/JOB'5Q,OAGP; MI'2I4*-O:UI MI\E.^R26LIOI!>K:6ISXC$T\+%.7Q/X8K=_Y+S/QX\7_`/!0;]IWXC:RVF>! M9;#P9#>.RZ?H'@SP_'KVN-$N<&74M5M;RXGD"?-));VUK&.6VJHX_3,-P9D& M!I*>+4L2X_%4K5'3IW\HP<8I=DY2?FSR9X_$R=J=J?915W^-_P`D>;W'[6W[ M5_A6[,=W\:M7?45=OM&F2_\`",:X;-_XHKQ8]*GM;:8'K`LK.O1E0\5W1X;X M=KQ]S*H*'22]K3OYQO.,FO.UGT;,_K6*@_XSOV]W3\+%?P?^TAKWB7Q9"W[0 M?Q*^.VN^$KITCFD\`>/I?#%UHK/("]Z-&L[1+?4;5%.3;6YM90%RC.?D:L3D M='#X9K)'OA[JGPYA^&_Q<^`7QN^('Q"^&OB/Q-X/T[Q%X(\<^*'\:Z/K_`(8\8:[9 M>'I]5\.ZA?P)=Z+K^F7.HQ7#0L=W^B7$4VQHVB?\[K8RGC7CLMSC*PG3JT:BXWO=>I&FZ7LZN'K2G3;BG&4N9-2: M5U?5-7N?"_BC_@H_^T7H_B?Q+I%G#\//LFD^(=;TRT,OAF_>7[-I^IW5I;F5 MUUU0TAAA3:I3IS=JL4KR@I.R]GM=G%+,,0I M224+)M+1]'ZGZZ?LR?$;Q%\6?@;X!^(7BM=/3Q!XCLM2N-172K:2RT\26NNZ MIIT7V>VEGF:)?L]G%D&1LMN/&<#\VS[`T,LS;&8+#IPD[M) M+>3Z+0]7#5)5*%.I*RD[[:+=H]XKR#<*`/RZ_;8_:^^+GP`^*6@>#_`4?A-M M(U'P-8>(;DZ[HUUJ%W_:%SKFO:?((YH-3ME2W^SZ;;X0H2&WG=\V!]_PKPUE MN<9?6Q.+=95*=>5->SFH+E5.G):.$M;R>M^QYN,Q57#U(PI\MG%/5=;M=_(Z M3]AK]JCXH_M"^)?'^D_$"/PQ':^&=#T74--_L#2;G393<7]_>6T_VEY]1N1+ M'Y<";0`F#DY.:PXLX>R_(Z&#J8)U>:O4G&7M)J2M&*:M:,;:L>!Q56M*HI\J M44FK*W5^9^D-?#GHA0`4`%`!0`4`%`!0`4`%`!0`4`%`'DOQ@^-WPX^!?AE_ M%'Q#U^'2[=B\6EZ5`%NM>UZ\5T5Y;O[*;,JM:G0CS5))_#EA#_Q*]&\+>&I66'2+:2,M MZ2*/2;. M?3M-1HI6^S,-F?"XDS;%Y/BJ-"-98S,O9JK/$58)TJ/.VHPPF&=Z5*UKNI)3 MJNZ7-N=.$H0K0E+E]G23LH1=F[;NVSA<)*([_4+NUG8-@E9K>0-W'->!0XSX@H5%*6,5>*> ML*M.FXONO=C&2^4D=,L!A6K*GR=G%M6_%K\#\*?C[\']2^`OQ3\1?#;5+]-2 M32S;7VCZN(UMO[6T'4XOM.F7TEN&(@N=F^">-695GMI@A*;2?US)LSIYOE]# M'4H>RY[QG"]^2I%VE%/2ZZQ?6+5];GB5Z+PU65)OX=GMH]O3S\S](?\`@EM\ M0+C4D^(?PFU-TOM,T;^S/B!X:@N-DZ:5=37;:9K7V57SY(>Z;2[E=F-DK3R# MYI6-?#^(&"C3>"S&DO9U*G-AZK6G,DN>%[>7/%]U9;(]#+)_Q*6ZC:45VOH_ MQLS\I?'7_(\^-O\`LI6&H6&J6D&H:7?6>HV%RGF6U[87,-W:7$9.-\%S;N\*_B7>:W;:YI^@6^@V MD>F^*TT&`Z7;W^H7\3-:&-O,E^U:A=@RYY`5?X*^@RCB'-LHPT\-@(4W1G4= M1\U'G?.XQB];JRM%:?/J9;O;^QTNSGU#4;VTTZPM8S-XFBMK>!&DFFGD2&&&-1N>221R%C0#)+,0!WKD2 M;:C%-MZ)):W\DB]O)+Y6/);W]H'X%:;>_P!FWWQB^&=K>[MAMI/&WAU71^FR M3&H$1-GC#E:]&&2YO*'/#+,4X=U0J?A[NOR,77H)\OM8)]N9?YGI6C:[HGB& MRCU+P_K&E:YITG$5_H^H6FIV4AP"0EU9321,<$'AN]<-6C5P\W3K4IT)Q^S. M+A)?*23-8N+7NM->3T_`U:S&%`!0`4`%`!0!\A_M%_M4Z=\)K[3_`()GMCNL[7;F5+7='++&C2,T%N#<+]+DG M#T\PA/'8RK]0RC#W=7$2TYK;QI)[OHY6:3T2E+W3DQ&)5%JG3CSUY?#%=+]7 M;;T_34Y;X+?LH:@OB5/C7^TIK$7Q/^--[LN;*SN]ESX/^'J%O.@TWPYIFT6L MEU:YVBX6(0Q.";9"X^TR]&:<105!Y5D5)Y?E<-)26E;$]'*I+XDI=K\S7Q.W MNJ:.%:E[;$/VE;HOLP\DMOZT[GY`_MJ:)X]T+]HWX@0>/=1U75I+W4)-4\(Z MCJ4C/!)X*OY'GT.UTE0!#!8V*,]B\,"JJSVRG_`.`S]W[IGI0S*@])1E3?I=?>M?P/ MI/1[S]E;]HF]&NZ;'\(_BEK,=HEJ9KO3]"U;Q%!8VYDEC@GLM3MO[1MK:-I9 M6"R0HJEWZ9->%4AQ#D,RZE>]HRJ0IN3M=IP?(V]-G=G3'ZK7?-'DJ/T M3=O1ZH]4\)_"SX:^`KVYU'P5X"\(>$K^[M?L5W>^'?#^EZ/=7%GYJ3_99Y[& MVB>6#SHXWV,2NY%.,BO/Q&88[%PC3Q6,K5X0?,HU*DYJ+M:Z4FTG9M7\S2%* MG2=Z=.--]TDOR/Y6/'7_`"//C;_L#X+NXN?$UY>ZUJ M.J3:KXDN+4(L.CP?;HK>"UN)8[<-"\DF^1U\KR)8'*0>._@ MW\3OA8MC_P`+$^'GB/P;!J3/%I\^L::L5A=RQKO>W@OK9Y;5KA4RQA\T2;06 MVX!->E@\SP&/Y_J.-I8ET]9*$O>BGU<7:5O.UO,RG1J4;<]-TUTNK+_(]P_9 M!_:'\3?`SXG^'+,:M=GX<^)]9L-%\7^')IY)-+AM]3N([*/Q!8VK-LLM4L)I MHYS+"$,T,)3P!_R)\3_`-A<_P#TU1-\S_CPZ>XO_2I&%^PWG_A"_P!KWEO^2$:IC+,< M?\2[Q+TR>*VXL_WKAKI_M\/_`$JF3@O@Q?\`UZ?ZGY]VC!)K5G=U2.:W=SO< M[461&8X#=E!.*^RDM))+6S_%'`NA]-_M,_M->,/V@/%4T#:AJ&G?#G2YA9># M_!D,LD5K);6RB&+5]8M(2!J>N784S,9A(+=9!#"%",TG@Y#D.&R7#IJ$98Z: MYJU>RNF]7"#?P4X[:6YG[TKWTZ<1B)UIVNXTUI&/IU:[O\#UW]@#Q9H_PF^( MWQ0\>>-4N]$\/^&O@OKFI7DUQ8SVTTZIXJ\(I;V5A'<1Q_:;ZZNGAMX(5.7E MF1<@$D>;QEAJN8X'+\'A+5*U?&TXQ2DFE>E6O*5KVC%7E)]$F;8"4:-2I.?N MQA3;VM]J.B]3QK]H/]J;XG?M":[=/K&IWNB>"A'L!DM&*I4XU,5;]YB)I.;=M>2_\."Z* M-G;63;,:^)J5Y:MQAT@M%\^[_I%;2/V.OVE=8T--?T[X,>)AIDD"W,$=T-(T MO4KBW=!)')!HNH:A!?,'0@JIMU8@C`Y%.IQ-D5&JZ$\TI*:=FX\\HI];SC%P MT_Q"6#Q'+S1HNWR3^ZZ9PW@+XC?%3]GWQG+?>$]3UOP1XCT>^-KK?AZ^AN;6 MSNI+:0&XTGQ-X]A/'+%=6LK#+P7*!OWB2!?P_/,HJY)C MZF$FW*G;GHU+6YZ4F^5]E)-.,TMI)]&CZ'#UXUJ:G%1[W7CFX M4`%`!0!\.?M>_M4S_!VVTWX:?#.W'B'XX>./LUGX?TJU@74#X692J8['/ZOE.$O*I)OD]HXKFE",N MD8K6I-;+W8^\].+%XGV*5*DKUIZ)+[-^MN[Z+YO0W?V5/V7;;X*Z==^-_'%T M?%?QP\:J]_XR\5W\YU&?3I+]AS99HUE(^U7:D-=21C&+>.&-,>(<_ MEFCT'Q_I#2W%AYLFA^(=-D6R\0^'[B8*))=-O M_+<>3)M3S;6=)K>78I>,LBLGJY3G..R6LZN"J(U3&0C-()M,N7'3?]IM`QYV*#Q^CX'C[+JJC''8>I@I]90_>T_P`.6HO3 MEEZL\JIEE6'\*2DNB?NO_+\CXF\=_`3XT_#(2R>./ACXPT"S@9E?53I4NHZ( M-OWF&M:0;JR"8YW-.O'-?58/.,JQME@\?1J2?V.=0G_X!/EE^!Q3H5J7QTI0 M7>VGWK0\KT^^N],O+75-)OKK3=1M)%GLM2TVZFLKZUE0ADEM;RTD26%PP!#( MXZ5Z,X1E&5.I!2IM6E"23BT^CB]'\T9IN+3B[..S6C7W'[E?L$?M=^(/BK-= M_"/XGWXU+QII.EOJGA?Q-*JQWGB;2+(QQZA8ZL(PJ3:Y9))%,+A54W,'FO(/ M-MW>;\EXPX:HY:HYEE\/986I/DJTE\-*D>)K>TA36?'VLZWK6K7PC`N9[?3M4N]"TFS>7& MYK:WMM/DDC3.U7O9V',C9_'^-\74K9W4H.35+!0IPA'HG*"J3E;O)RLWU45V M/=R^"AAU)*SFVW\FTOZ\SV']L'PKIOBW]FSXMV.HVT,QTOPEJ'B73I)45GLM M4\-Q_P!L6=W;L1F&8-:/'N7!*3R(?ED8'S.&<14PN>Y;*G)QYZT:4DM+PJOD MDGY:W]4GNC7%P3PU5-;1;7DUJ?S$([1M'(AVLCI(I'&&5@RD?0@5^]M;KIV] M3YL_0O\`X*1SR77Q;^&ES*N&O^P^' M_I5(6"^#%_\`7I_J?GHI`12>@0$_0"OLS@/Z&_V'OV:/!WPU^%?A7QYK&@:? MJ7Q'\;Z3:>);S6=2M(;J[T/3=5B2\TC1=',ZM_9T<>GR6TD[PA))9YI=[%$C M5/Q;BO/<3C+_\`!4_QIWOM2 MTRQTK2H]8EE\3A$AT:>XLY+F%3!:-+<7:N6.V>UMSM../N\_PN88W+*V#RV4 M*=>NXQE*<^1*EO-)I/66D7WBY'G8:=*E6C.JGRPNTDNO333;?U/U^_X>;?LV M?\^_Q*_\(^'_`.7-?FG^H6>]\+_X.?\`\@>M_:6'_O\`_@/_``3\R_VT_C%\ M'?CGXY\.^//A=::_9:HVBRZ1XR&N:''HQOI+":-M"OT:.]G^UW(M)[JUD8[2 ML5I:KD@#;]YPME>9Y/A*^#Q\J;IJ:G0]G4Y^7F3]I'X8\JNE)=W*3/-QE6C6 MG&=).+M:5U;T>_JCV[_@EUXVNM*^+/C7P&TSC3/%G@\ZTEMN/EC6/#-_;)%, M$Z!VTW5KY6(ZB*,'.T8\KC_"1EEN%Q:5IX:MR-_W*L7=?^!0C][[FV63Y:LZ M>RE&]O-/_)L_=.OR0]L*`"@#S'XR_$W2O@W\,O&'Q'U=!-;^&=)EN;6QWB-M M2U6=TM-'TN-L@JUWJ=Q:PEADJLC/@A#7?E>`J9EC\-@:3Y77FDY?R07O3G_V M[%-^;TZF5:HJ%*=1[16BVUZ+YL_,7_@GSX"U3XN_$?XA?M2?$F0ZUKD&LW&E M>'KBZ3=`OB34+1)]9U"TC8D01:7HUSI^FV4:C;#'>2A<-"I'WO&>,IY7@<%P M_@%["BX*=1+1^RB[0BWU=2:E4F]Y.*OHV>=@*;J5*F)J:M.T?5[OY)V7J?L1 M7YF>L<9\1M1UW1_A]XYU;PN8AXDTOPAXDU'0//MQ=0_VS8Z/>76F^;:EE%Q' M]LBAS%D;Q\N>:ZL#"C/&82G7O["=:E&I9\KY)3BI6?3W6]>A%1R5.;C\2BVO M5*ZT]3\$%_X*/_M1E5/]M>"1E0?^1+MQC(ST^W5^P?ZC\/\`_/JO_P"#W_\` M(GA_VAB>\?\`P'_@G[9_LX_%'_A*V\3Z M>39ZY;&T1V^Q_P"FPR2)"3Q%-$PRKJ3^5YYE_P#9>:8S!QBX4JSAZOM:-.=]6M;:6?73IJ>VNB2(TB: M5%%9V%^^E)IUQ!K\6G0!8[2Z9KY[>X>)$28M`S#S%=I/UG@3,\;C*.,PF)J2 MK4L(J;I3FVY1Y^9.FY/5KW>:*;;6JV:2\7,:-.E*G."4'*]TM.VMOGKW/F3] MB-]0B_:F^$7]G;Q*VL:M']Q6H?ZOYDI M[*$&O\7M8):.+/]ZX:_[#X?\` MI5(6"^#%_P#7I_J?GD?]2?\`KD?_`$"OM.OS.`_K?^'"JOP\\!JH"JO@SPNJ MJ!@*HT.Q```Z`#BOYPQW^^XS_K_5_P#3DCZJG_#A_AC^2/RK_P""K>BW6/@O MXB56-C&_C'0Y7`.V&[F30]0ME9N@,L-M>$#C/V=J_0O#NK%?VI0^&7[FHEY+ MVD7]S:^\\S-(V]C):)Z3!97%U\<&%HQK552E)PT;5K;K6WW79^E?\`PZF^'O\`T5OQ MU_X*?#G_`,CU\+_Q$/&_]"W#_P#@=7_,]'^RZ?\`S]E]R,W4O^"8'PET6.*7 M6/CCXHTF*9S'#)J5OX2L(Y9`I<3X_,\`\'B;8;!TJ%15(57)I-6TZ^A^A-?&'>%`!0!\$?\`!2#0O$6L_LVW M;Z#:7=Y;:)XP\.ZYXCALXWE>+0+2/4H9KR6*)2S6MM?W6GS2MC$:1F5L+&Q' MV'`]6A0SR*JR5-U:-2G2;T7M&XM13?645)+NW9:LXZ,UJT94(+9S_`';?^&,K M2E_VZGW)4X7Y8R5_+6WK;1'\]'[8G[,.O_`/Q[JFL:9IMS2TT26_EDN)/"NKRH"+*ZM9&=+5Y=J7-NL91C*DJ1_M'#.?4&EAYMQ7[J3O%]K_`&7V\NZ/)_@S M^T3\6?@'?75U\.?$8LK#4I(YM6\.:I;+J?AS5)8E")<7&G2.AM[P1@)]JM9; M>;:`K.R@*/2S3),NSB$8XVAS3IJT*D'R5()]%);QOKRR35];7,:.(JX9OV5T%A<#05"G>[WG-.3UE*VGDM$DCBJ59U9^GM=45!J?BJ6WE"R6UM-9C['9[U M#2QW-U-@1M"TGY]QOGM&I".3X2HI\LU/$RB[Q3C\-)-:-J7O3MLU%;WMZ>78 M:47[>:Y=+03TWWE^B[ZOL?DSXZ_Y'GQM_P!CAXH_]/M_7Z-A/]TPG_7FE_Z; MB>5/XY_XG^;/Z,/V%_\`DU3X1_\`8+US_P!2O7J_$N+?^2AS+_'3_P#3-,^A MP7^ZTO1_^E,]'_:3_P"3??C3_P!DQ\:?^F"^KAR+_DX_FQW[#?_`")?[7O_`&0C5/\`TW>):.+/]ZX: M_P"P^'_I5(6"^#%_]>G^I^>1_P!2?^N1_P#0*^TZG`?UP?#K_DGW@3_L3?#' M_IDL:_G#'?[[B_\`K]5_].2/JJ?\.'^&/Y(\I_:C^!\'Q^^$&O>!XI(;3Q#; MR0Z_X/OI\+#:>)=+28VD=P^,QV=Y!/=6,S#[L=ZTF&,8!]#A_-GDV94<6TW0 M=Z=:*W=*=N:WG%I3CW<;=3+$T%7HR@M)+6/2S7^>J^9_-G!-X]^#'Q!AF$>I M^"OB'X"UM)EBN8?*OM*U2SRVX=AN:..Z<#)"D#&/A:WA MYAW5;P^93I46[\DZ2G**[*2G!/U<4>E',Y)6=%$]'CE71]%%ZT8N)(A.SS:AJER8X4DNIB781I' M&D:`)7UN39'@LBHSI812=2I9U:TVN>?+>R=K*,(W;45HKMMMZG#7Q%2O).=H MJ/PQ6RO^OF?L!_P3S_9QU#X0>`M4\?>+M+;2O&WQ'2R:'3+F#R;[0?"5GOFT MRRNT(#6]_?7$SWL\#`&-5LXW`EB=5_-.-,[AF.,IX/"U.?"8'FO)/W:E:6DI M1[QBERQ?5\S6C3/6R_#NA!SDN6=3IM:/3YO=_(_1.OBCT`H`*`&2Q1S1R0S1 MI+#*CQ2Q2HLD&;NZ,4_*\?P32-WPY^RG^SQX4DADTG MX4^&7>WP83K*WWB18R.0R1^([R^13G!R%'05C7XASJNFJF858I[\G+2_]-1@ MQQPN'A\-):=[O\[GO%C86.E6L5CIEE::;96Z[8+.QMH;.U@7^[%;VZ)'&OLJ MBO(G.W4S%S!X4UA6T=7;)8II&M MVU]';J6.=EN\"#HJ@<#Z[!\<9WA8J%65+&1CUJPM/_P.FX-^LDVSBGEV'?PI MT_\`"]/N=[?(\J@_X)4?#9)E:?XJ^/I8`V6ACT_PW!(RY^Z)C92!#COL/TKT M7XA8ZUHY=AXOOS57;YB7Z'T;\+_P!A+]G3X6WUMK%KX5N? M%^NV3QS6NJ^.KX:]]EN(^5GM=*$$&F0RAOF5_L3.I`*L",UX>/XNSO'0E2>( M6$HRNG##Q]G=/HYW=1KRYK/L=%+`X>BTU'FE'9RUM\M%^!]B``````````8` M`X``'05\R=9\/ZE_P3P_9DU34=0U6\\.^)VO-3O[S4KMD\9Z[$C75_7X:[?*T[W M^)]3ZJ^''P]\,_"GP7H?@#P=;W-IX;\.0W$&EV]Y>3ZAKO^IK>+?"^D>-?"_B#P?KT4TVB>)M'U#0M6AMYY+2>33]3MI+2[CAN8 M2'MY&AE<"1"&4G(Y%98;$5,)B*.)HM1JX:<:D&TFE*+4E=/1JZVZCE%2C*#^ M&2::VT>_H?&7_#N']EP8`\.>*<#I_P`5MKXZ?]O-?4?Z[Y^O^7U+3_IQ3_R. M/^S\-_++_P`"9ZA\5OV0?@G\9M9T;7O'>CZW>:CH'ARQ\*Z=)8>)-5TN./1] M.N+NYM8I(;295EF$M[<$RL"S!@"?E%<&7<2YKE5*K1P=2G"G5JRJR4J4)/GD MDFTVM%:*TV-:N$HU'%SB[Q7*K-K3Y>HOPY_9"^"?PKT_QSIG@_1];M+3XB>& MYO"?B=;SQ)JE^]SHT\5W#)#:OW'[V+:PW`Y^448WB7-W;_P`( MWXJQC;_R.VO],8_Y^?2N_P#UXX@_Y_TO_!%/_(R_L[#?RR_\"9]P:5IMKHVE MZ;H]BKI8Z386>FV:2.TKI:V-O':VZO(Y+2.(8D!9N21D\FOE*DY5:DZL_CJ2 ME*5M-9-MZ=-6=J2BE%;15E\B_4#/#_B_^SE\'OCE;QI\0_!]GJ.I6T)@L?$5 MC)+I/B2PC)R([?6;%HYG@!R1!<&>$%B?+R2:];+,[S/)Y/ZCB73IR=Y4Y)2I M-]W"5TGYQM+S,:N'HUE^\AJMFM&OFO\`ACXUO/\`@EE\&I+PRV/CWXE6-EO8 MBR>Y\.WCJIZ(MW)H2MQZLC$]Z^GAX@YI&-I8/"REW2J1_P#)54M^1Q_V91OI M.:7;3_(]_P#A'^P_^S_\'=3M?$&D^&[SQ/XFL766QU[QK>KK=QI\ZCBXTZP% MO!I]CE@J%!IQCS26SEK;T6B7W'UW7S9UA0`4`%`'__V3\_ ` end